Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 27 min 56 sec ago

Sirtex Medical Inc. Announces 21.2 Percent Dose Sales Growth of SIR-Spheres(R) Y-90 resin microspheres in Fourth Quarter

Thu, 08/13/2015 - 15:23
Increase of 18 Percent in Hospitals Certified to Administer Procedure WOBURN, Mass.--(Healthcare Sales & Marketing Network)--Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (SRX.AX), a leading manufacturer of targeted, liver cancer therapies...
Devices, Oncology, Interventional
Sirtex Medical, SIR-Spheres, radiotherapy, liver cancer

Avinger, Inc. Announces Early 510(k) Filing for Pantheris(TM)

Wed, 08/12/2015 - 13:27
REDWOOD CITY, Calif., Aug. 12, 2015 -- (Healthcare Sales & Marketing Network) -- Avinger, Inc., (AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascul...
Devices, Interventional, FDA
Avinger, lumivascular, Pantheris, atherectomy

Premier, Inc. Acquires Healthcare Analytics Leader Healthcare Insights, LLC

Wed, 08/12/2015 - 13:22
Enhancing Enterprise Resource Planning Solution With New Budgeting Capabilities CHARLOTTE, N.C., Aug. 12, 2015 -- (Healthcare Sales & Marketing Network) -- Premier, Inc. (PINC), a leading healthcare improvement company, today announced that it has acqui...
Devices, Group Purchasing, Mergers & Acquisitions
Premier Purchasing, Healthcare Insights

Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials

Wed, 08/12/2015 - 13:13
Safety Clearance is Another Step Towards the Start of Phase II CLI Trial Via Japan's Accelerated Approval Pathway HAIFA, Israel, Aug. 12, 2015 -- (Healthcare Sales & Marketing Network) -- Pluristem Therapeutics Inc. (PSTI.TA) (PSTI.TA), a leading develo...
Regenerative Medicine, Regulatory
Pluristem Therapeutics, PLX-PAD, stem cell, critical limb ischemia

Rich Pharmaceuticals, Inc. Appoints Richard Salvador, Ph.D., Research and Development Expert, To Board of Directors

Tue, 08/11/2015 - 17:26
BEVERLY HILLS, Calif., Aug. 11, 2015 -- (Healthcare Sales & Marketing Network) -- Rich Pharmaceuticals, Inc. (RCHAE) ("Rich Pharmaceuticals" or the "Company") announced today that Dr. Richard A. Salvador will be joining the corporate b...
Biopharmaceuticals, Oncology, Personnel
Rich Pharmaceuticals, Acute Myelocytic Leukemia, Myelodysplastic Syndromes

Ovid Therapeutics Completes Oversubscribed $75 Million Series B Financing

Tue, 08/11/2015 - 16:48
Ovid is developing therapies for rare and orphan diseases of the brain based on novel and proprietary insights into the genetics and molecular biology of neurological disorders NEW YORK--(Healthcare Sales & Marketing Network)--Ovid Therapeutics Inc. (Ov...
Biopharmaceuticals, Neurology, Venture Capital
Ovid Therapeutics

BioMark Appoints Dr. Thomas Malcolm to Lead U.S. Operations

Tue, 08/11/2015 - 16:00
VANCOUVER, British Columbia, Aug. 11, 2015 -- (Healthcare Sales & Marketing Network) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (20B.F) (BMKDF) is pleased to announce the appointment of Thomas Malcolm, Ph.D., as Chief Scientific Officer an...
Diagnostics, Oncology, Personnel
BioMark Diagnostics

Axiobionics(R) Announces the Launch of its Newest Therapy Device: TripleFlex

Tue, 08/11/2015 - 15:57
TripleFlex is a first of its kind device that corrects hip, knee, and foot drop while putting energy back into the patient's step ANN ARBOR, Mich., Aug. 11, 2015 -- (Healthcare Sales & Marketing Network) -- Axiobionics, a leading medical device company...
Devices, Neurology, Product Launch
Axiobionics, TripleFlex, Wearable Therapy

FDA Approves Orbera(TM) Bariatric System

Tue, 08/11/2015 - 15:44
Apollo Endosurgery Names Dr. Adam Smith Spokesperson FORT WORTH, Texas, Aug. 11, 2015 -- (Healthcare Sales & Marketing Network) -- The ORBERA™ Managed Weight Loss System received its final approval on Wednesday, August 5th and Ultimate Bariatrics is pr...
Devices, Gastroenterology, Surgery, FDA
Apollo Endosurgery, Orbera, Bariatric System, bariatric surgery

Celgene Receives Antitrust Clearance for Receptos Acquisition

Tue, 08/11/2015 - 15:41
SUMMIT, N.J.--(Healthcare Sales & Marketing Network)--Celgene Corporation (CELG) today announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) with respect to the previously announced tender offer...
Biopharmaceuticals, Mergers & Acquisitions
Celgene, Receptos, Ozanimod

CyMedica Orthopedics(R) Receives CE Mark For The CyMedica QB1(TM) Muscle Activation System

Tue, 08/11/2015 - 15:37
SCOTTSDALE, Ariz., Aug. 11, 2015 -- (Healthcare Sales & Marketing Network) -- CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FD...
Devices, Orthopaedic, Regulatory
CyMedica Orthopedics, QB1, Muscle Activation System

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong